Salesforce vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

Salesforce generated FY2026 revenue of nearly $41.5B (+9.6% YoY), net income of about $7.5B, and $14.4B in free cash flow, while UiPath reached profitability with $1.6B of revenue (+12.7%), $282.3M of net income, and $352.2M of free cash flow. The article favors Salesforce, citing Agentforce adoption, more than 2x YoY growth in its AI and data-cloud business, stronger scale, and a lower 14.2x forward P/E versus UiPath's 17.0x. UiPath's debt-free balance sheet and four consecutive profitable quarters support its turnaround, but customer concentration, slower growth, and elevated stock-based compensation remain risks.

Analysis

The relevant divide is not mature versus growth software; it is control of the enterprise workflow and data layer. CRM can monetize AI through existing seats, attached Data Cloud consumption, and lower service-delivery costs, while PATH must prove that agentic workflows expand automation budgets rather than replace standalone RPA licenses. MSFT is the key competitive constraint: Copilot’s distribution can pressure both vendors, but CRM’s installed system-of-record position gives it materially greater switching-cost protection than PATH’s point-solution footprint.

Cash-flow quality matters more than the reported profitability comparison. High stock-based compensation means PATH’s apparent free-cash-flow conversion is unlikely to translate one-for-one into per-share value unless dilution falls sharply; this is especially consequential for a company whose multiple depends on a durable reacceleration. For CRM, the near-term catalyst path is AI/data attach rates and renewal uplift over the next 1-3 quarters; the 6-18 month question is whether AI revenue is incremental enough to offset core-seat growth maturation and preserve operating leverage.

Consensus likely overweights the binary "Agentforce winner" narrative and underweights procurement friction. Enterprise AI pilots can create impressive deal counts without commensurate production consumption, so paid-deal disclosures alone are not sufficient evidence of a revenue inflection. CRM is attractive only if reported remaining performance obligations, subscription growth, and Data Cloud/AI consumption confirm acceleration; PATH is a higher-beta turnaround but needs net-new ARR and dollar-based retention evidence before its profitability deserves a structural rerating.

Key Decisions for Investors

• Favor a 3-6 month long CRM / short PATH pair, sized beta-neutral: CRM has a more defensible distribution and data moat, while PATH is more exposed to AI-driven automation commoditization and dilution. Target 10-15% relative outperformance; exit if PATH reports two consecutive quarters of accelerating net-new ARR and retention expansion while CRM subscription growth decelerates below management’s long-term framework.
• Do not add outright PATH exposure on GAAP profitability alone. Set an earnings alert for evidence that operating cash flow excluding stock-based compensation is sustainably positive and share count stabilizes; absent that, use PATH rallies after headline AI announcements as short-entry windows rather than confirmation of a turnaround.
• For CRM, initiate only around earnings or material AI-consumption disclosures rather than chasing promotional deal-count headlines. A 6-9 month call spread can express upside while limiting multiple-risk: buy near-ATM calls and sell 15-20% out-of-the-money calls; the thesis fails if backlog/RPO and subscription growth do not improve despite AI investment.
• Monitor MSFT’s Copilot and Power Platform enterprise adoption as the leading competitive indicator. Faster bundled-agent adoption would be negative for PATH first and could cap CRM’s AI multiple, supporting a tactical short PATH / long MSFT hedge if CRM’s AI monetization remains unverified.